(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.08%) $0.927
(0.11%) $10.85
(0.05%) $0.793
(-0.13%) $92.46
1.83% KRW 8 890.00
Live Chart Being Loaded With Signals
Prestige BioPharma Limited, a biopharmaceutical company, engages in the research, development, and marketing of biosimilars and new antibody therapeutics in the Asia Pacific...
Stats | |
---|---|
Today's Volume | 79 940.00 |
Average Volume | 53 049.00 |
Market Cap | 534.25B |
EPS | KRW-238.40 ( 2023-03-31 ) |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW10.64 (0.12%) |
Volume Correlation
Prestige BioPharma Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Prestige BioPharma Correlation - Currency/Commodity
Prestige BioPharma Financials
Annual | 2022 |
Revenue: | KRW161.84M |
Gross Profit: | KRW-11.50B (-7 103.88 %) |
EPS: | KRW293.60 |
Q2 | 2023 |
Revenue: | KRW119.89M |
Gross Profit: | KRW-3.72B (-3 104.33 %) |
EPS: | KRW-216.79 |
Q1 | 2023 |
Revenue: | KRW67.32M |
Gross Profit: | KRW-3.35B (-4 972.45 %) |
EPS: | KRW-151.80 |
Q4 | 2022 |
Revenue: | KRW161.06M |
Gross Profit: | KRW-3.25B (-2 020.78 %) |
EPS: | KRW-146.55 |
Financial Reports:
No articles found.
Prestige BioPharma
Prestige BioPharma Limited, a biopharmaceutical company, engages in the research, development, and marketing of biosimilars and new antibody therapeutics in the Asia Pacific. The company primarily engages in the development of new and similar antibody drugs for solid tumor, pancreatic cancer, breast cancer, gastric cancer, and arthritis. It is also developing vaccines for COVID-19 virus. The company was incorporated in 2015 and is headquartered in Singapore.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators